China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
21.93
-0.39 (-1.75%)
At close: Feb 13, 2026

SHE:300294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
761.751,3001,9611,5321,584753.89
Trading Asset Securities
2,3552,1993,3623,1942,700-
Cash & Short-Term Investments
3,1163,4995,3244,7264,284753.89
Cash Growth
-40.52%-34.28%12.66%10.31%468.21%32.55%
Accounts Receivable
732.8509.38275.92567.02588.08681.01
Other Receivables
88.739.81264.4100.6267.953.21
Receivables
821.5549.19540.32667.64655.98734.22
Inventory
1,119995.43556.94666.96676.84689.46
Other Current Assets
57.4314.756.4313.2529.4750.08
Total Current Assets
5,1155,0586,4286,0735,6462,928
Property, Plant & Equipment
1,5021,170676.62722.81771.33809.52
Long-Term Investments
131.2681.09100.39117.09144.96311.66
Goodwill
72872872.61663.84663.84663.84
Other Intangible Assets
663.59773.28269.31312.17169.47198.6
Long-Term Deferred Tax Assets
76.2573.5447.3444.9927.4420.57
Long-Term Deferred Charges
139.41145.988.1582.64161.62166.41
Other Long-Term Assets
372.51370.79146.8316.2437.260.27
Total Assets
8,7278,4017,8298,0337,6225,159
Accounts Payable
521.65357.62126.35303.46277.53285.88
Accrued Expenses
91.14318.03274.14290.9261.1983.94
Short-Term Debt
-----220.2
Current Portion of Long-Term Debt
--0.0322.180.0855.2
Current Portion of Leases
2.555.330.872.812.06-
Current Income Taxes Payable
13.7312.448.5827.0941.4520.54
Current Unearned Revenue
5.734.0812.2120.5812.9714.51
Other Current Liabilities
283.6952.8834.2638.3335.66191.66
Total Current Liabilities
918.5750.38456.45705.34630.94871.93
Long-Term Debt
1.16-22.15-22.1555
Long-Term Leases
4.367.171.410.3711.3-
Long-Term Unearned Revenue
17.8619.5123.5227.0930.9832.44
Long-Term Deferred Tax Liabilities
112.78136.324.565.565.946.71
Total Liabilities
1,055913.38508.07748.35701.3966.08
Common Stock
504.25504.25504.25504.25511.63433.32
Additional Paid-In Capital
4,0634,0634,0634,0654,2581,947
Retained Earnings
3,1042,9182,7532,6162,2591,928
Treasury Stock
-----199.96-199.96
Comprehensive Income & Other
-0.682.36----
Total Common Equity
7,6717,4877,3207,1866,8294,108
Minority Interest
1.690.611.0799.1991.484.55
Shareholders' Equity
7,6727,4887,3217,2856,9204,192
Total Liabilities & Equity
8,7278,4017,8298,0337,6225,159
Total Debt
8.0812.5124.4535.3635.58330.39
Net Cash (Debt)
3,1083,4865,2994,6904,248423.5
Net Cash Growth
-40.62%-34.21%12.99%10.41%903.09%-
Net Cash Per Share
6.186.9410.499.339.740.99
Filing Date Shares Outstanding
504.25504.25504.25504.25504.25425.94
Total Common Shares Outstanding
504.25504.25504.25504.25504.25425.94
Working Capital
4,1964,3085,9715,3685,0152,056
Book Value Per Share
15.2114.8514.5214.2513.549.64
Tangible Book Value
6,2795,9866,9786,2105,9963,245
Tangible Book Value Per Share
12.4511.8713.8412.3111.897.62
Buildings
-741.4527.95518.01536.62506.23
Machinery
-839.25625.83671.97665.73632.37
Construction In Progress
-32139.9469.3440.8680.9
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.